Physician profile
Mark Schulke
NPI 1922211341
$923.83
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $435 · 2022: $424 · 2023: $42.27 · 2024: $22.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $65.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $65.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $239.31 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $87.56 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.81 | 2021 | |
| Xeris Pharmaceuticals, INC. | $44.22 | 2021-2022 | |
| Exact Sciences Corporation | $42.79 | 2023-2024 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $40.82 | 2021 | |
| Abbott Laboratories | $39.05 | 2022 | |
| Amgen INC. | $33.63 | 2021-2022 | |
| Dexcom, INC. | $31.68 | 2021 | |
| Amarin Pharma, INC. | $30.67 | 2021 | |
| Paratek Pharmaceuticals, INC. | $27.21 | 2021-2022 | |
| Medtronic, INC. | $25.79 | 2022 | |
| Vistapharm, INC. | $25.03 | 2021 | |
| Merck Sharp & Dohme LLC | $24.86 | 2022 | |
| Lilly USA, LLC | $23.27 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.61 | 2021 | |
| Pfizer INC. | $19.57 | 2021 | |
| Sanofi Pasteur INC. | $16.94 | 2021 | |
| Eyevance Pharmaceuticals LLC | $16.31 | 2021 | |
| Hikma Pharmaceuticals USA | $16.31 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.71 | 2022 | |
| Phadia US INC. | $12.68 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.02 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Schulke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.